These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 19363796)

  • 1. TranScreen-N: Method for rapid screening of trans-ungual drug delivery enhancers.
    Murthy SN; Vaka SR; Sammeta SM; Nair AB
    J Pharm Sci; 2009 Nov; 98(11):4264-71. PubMed ID: 19363796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ungual and transungual drug delivery.
    Shivakumar HN; Juluri A; Desai BG; Murthy SN
    Drug Dev Ind Pharm; 2012 Aug; 38(8):901-11. PubMed ID: 22149347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trans-ungual Delivery of AR-12, a Novel Antifungal Drug.
    Kushwaha AS; Sharma P; Shivakumar HN; Rappleye C; Zukiwski A; Proniuk S; Murthy SN
    AAPS PharmSciTech; 2017 Oct; 18(7):2702-2705. PubMed ID: 28289970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ungual and trans-ungual iontophoretic delivery of terbinafine for the treatment of onychomycosis.
    Nair AB; Kim HD; Chakraborty B; Singh J; Zaman M; Gupta A; Friden PM; Murthy SN
    J Pharm Sci; 2009 Nov; 98(11):4130-40. PubMed ID: 19340887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nail swelling as a pre-formulation screen for the selection and optimisation of ungual penetration enhancers.
    Khengar RH; Jones SA; Turner RB; Forbes B; Brown MB
    Pharm Res; 2007 Dec; 24(12):2207-12. PubMed ID: 17665289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Terbinafine Hydrochloride Trans-ungual Delivery via Nanovesicular Systems: In Vitro Characterization and Ex Vivo Evaluation.
    Elsherif NI; Shamma RN; Abdelbary G
    AAPS PharmSciTech; 2017 Feb; 18(2):551-562. PubMed ID: 27138036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydration of nail plate: a novel screening model for transungual drug permeation enhancers.
    Chouhan P; Saini TR
    Int J Pharm; 2012 Oct; 436(1-2):179-82. PubMed ID: 22705091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trans-ungual iontophoretic delivery of terbinafine.
    Nair AB; Vaka SR; Sammeta SM; Kim HD; Friden PM; Chakraborty B; Murthy SN
    J Pharm Sci; 2009 May; 98(5):1788-96. PubMed ID: 18781625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insights into drug delivery across the nail plate barrier.
    Saner MV; Kulkarni AD; Pardeshi CV
    J Drug Target; 2014 Nov; 22(9):769-89. PubMed ID: 24964054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Permeation studies of novel terbinafine formulations containing hydrophobins through human nails in vitro.
    Vejnovic I; Huonder C; Betz G
    Int J Pharm; 2010 Sep; 397(1-2):67-76. PubMed ID: 20620203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iontophoretic drug delivery across the nail.
    Delgado-Charro MB
    Expert Opin Drug Deliv; 2012 Jan; 9(1):91-103. PubMed ID: 22149385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study on the effect of inorganic salts in transungual drug delivery of terbinafine.
    Nair AB; Sammeta SM; Vaka SR; Narasimha Murthy S
    J Pharm Pharmacol; 2009 Apr; 61(4):431-7. PubMed ID: 19298688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a novel penetration enhancer on the ungual permeation of two antifungal agents.
    Traynor MJ; Turner RB; Evans CR; Khengar RH; Jones SA; Brown MB
    J Pharm Pharmacol; 2010 Jun; 62(6):730-7. PubMed ID: 20636860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transungual drug delivery: current status.
    Elkeeb R; AliKhan A; Elkeeb L; Hui X; Maibach HI
    Int J Pharm; 2010 Jan; 384(1-2):1-8. PubMed ID: 19819318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic approach to the formulation of anti-onychomycotic nail patches.
    Rizi K; Mohammed IK; Xu K; Kinloch AJ; Charalambides MN; Murdan S
    Eur J Pharm Biopharm; 2018 Jun; 127():355-365. PubMed ID: 29530581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efinaconazole topical solution, 10%: formulation development program of a new topical treatment of toenail onychomycosis.
    Bhatt V; Pillai R
    J Pharm Sci; 2015 Jul; 104(7):2177-82. PubMed ID: 25940933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancing the nail permeability of topically applied drugs.
    Murdan S
    Expert Opin Drug Deliv; 2008 Nov; 5(11):1267-82. PubMed ID: 18976136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent Patents on Permeation Enhancers for Drug Delivery Through Nails.
    Kreutz T; de Matos SP; Koester LS
    Recent Pat Drug Deliv Formul; 2019; 13(3):203-218. PubMed ID: 31663846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ciclopirox delivery into the human nail plate using novel lipid diffusion enhancers.
    Hafeez F; Hui X; Selner M; Rosenthal B; Maibach H
    Drug Dev Ind Pharm; 2014 Jun; 40(6):838-44. PubMed ID: 23600655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of topical therapeutics for management of onychomycosis and other nail disorders: a pharmaceutical perspective.
    Elsayed MM
    J Control Release; 2015 Feb; 199():132-44. PubMed ID: 25481439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.